Jie Sun1, Gador Canton1, Niranjan Balu1, Daniel S Hippe1, Dongxiang Xu1, Jin Liu1, Thomas S Hatsukami1, Chun Yuan2. 1. From the Departments of Radiology (J.S., N.B., D.S.H., D.X., C.Y.), Mechanical Engineering (G.C.), Bioengineering (J.L., C.Y.), and Surgery (T.S.H.), University of Washington, Seattle. 2. From the Departments of Radiology (J.S., N.B., D.S.H., D.X., C.Y.), Mechanical Engineering (G.C.), Bioengineering (J.L., C.Y.), and Surgery (T.S.H.), University of Washington, Seattle. cyuan@uw.edu.
Abstract
OBJECTIVE: Effective prevention and management strategies of intraplaque hemorrhage (IPH) remain elusive because of our limited knowledge regarding its contributing factors. This hypothesis-generating study aimed to investigate associations between cardiovascular risk factors and IPH for improved understanding of the pathogenesis of IPH. APPROACH AND RESULTS: Asymptomatic subjects with 16% to 79% stenosis on ultrasound underwent carotid magnetic resonance imaging using a large-coverage, 3-dimensional magnetic resonance imaging protocol. Individual plaques (maximum thickness >1.5 mm) in bilateral carotid arteries were identified, and presence of IPH was determined. From 80 subjects, 176 de novo plaques were measured, of which 38 (21.6%) contained IPH. Blood pressure (BP), primarily low diastolic BP, was associated with IPH in multivariate analysis adjusted for age, sex, and plaque size (odds ratio with 95% confidence interval per 10-mm Hg increase: 0.51 [0.30-0.88]), which was little changed after adjusting for antihypertensive use and systemic atherosclerosis. Antiplatelet use was associated with IPH in age and sex-adjusted models (P=0.018), for which a trend remained after considering plaque size and past medical history (odds ratio for aspirin alone versus none: 3.1 [0.66-14.8]; odds ratio for clopidogrel or dual therapy versus none: 5.3 [0.80-35.0]; P=0.083). CONCLUSIONS: Low diastolic BP was independently associated with IPH, which was not attributed to treatment difference or BP changes from systemic atherosclerosis. Hemodynamic changes from lowering diastolic BP may be the pathophysiological link. Prospective serial studies are needed to assess whether BP and antiplatelet use are associated with the development of new or repeated IPH.
OBJECTIVE: Effective prevention and management strategies of intraplaque hemorrhage (IPH) remain elusive because of our limited knowledge regarding its contributing factors. This hypothesis-generating study aimed to investigate associations between cardiovascular risk factors and IPH for improved understanding of the pathogenesis of IPH. APPROACH AND RESULTS: Asymptomatic subjects with 16% to 79% stenosis on ultrasound underwent carotid magnetic resonance imaging using a large-coverage, 3-dimensional magnetic resonance imaging protocol. Individual plaques (maximum thickness >1.5 mm) in bilateral carotid arteries were identified, and presence of IPH was determined. From 80 subjects, 176 de novo plaques were measured, of which 38 (21.6%) contained IPH. Blood pressure (BP), primarily low diastolic BP, was associated with IPH in multivariate analysis adjusted for age, sex, and plaque size (odds ratio with 95% confidence interval per 10-mm Hg increase: 0.51 [0.30-0.88]), which was little changed after adjusting for antihypertensive use and systemic atherosclerosis. Antiplatelet use was associated with IPH in age and sex-adjusted models (P=0.018), for which a trend remained after considering plaque size and past medical history (odds ratio for aspirin alone versus none: 3.1 [0.66-14.8]; odds ratio for clopidogrel or dual therapy versus none: 5.3 [0.80-35.0]; P=0.083). CONCLUSIONS: Low diastolic BP was independently associated with IPH, which was not attributed to treatment difference or BP changes from systemic atherosclerosis. Hemodynamic changes from lowering diastolic BP may be the pathophysiological link. Prospective serial studies are needed to assess whether BP and antiplatelet use are associated with the development of new or repeated IPH.
Authors: K-Raman Purushothaman; Meerarani Purushothaman; Paul Muntner; Patrick A Lento; William N O'Connor; Samin K Sharma; Valentin Fuster; Pedro R Moreno Journal: Vasc Med Date: 2011-04 Impact factor: 3.239
Authors: Wouter J M Derksen; Wouter Peeters; Claudia Tersteeg; Jean-Paul P M de Vries; Dominique P V de Kleijn; Frans L Moll; Allard C van der Wal; Gerard Pasterkamp; Aryan Vink Journal: Atherosclerosis Date: 2010-10-23 Impact factor: 5.162
Authors: Emoke Nagy; John W Eaton; Viktória Jeney; Miguel P Soares; Zsuzsa Varga; Zoltán Galajda; József Szentmiklósi; Gábor Méhes; Tamás Csonka; Ann Smith; Gregory M Vercellotti; György Balla; József Balla Journal: Arterioscler Thromb Vasc Biol Date: 2010-04-08 Impact factor: 8.311
Authors: Nishath Altaf; Stephen D Goode; Andrew Beech; John R F Gladman; Paul S Morgan; Shane T MacSweeney; Dorothee P Auer Journal: Radiology Date: 2010-12-16 Impact factor: 11.105
Authors: Robert M Kwee; Robert J van Oostenbrugge; Martin H Prins; Johannes W M Ter Berg; Cees L Franke; Arthur G G C Korten; Bé J Meems; Jos M A van Engelshoven; Joachim E Wildberger; Werner H Mess; M Eline Kooi Journal: Stroke Date: 2010-05-13 Impact factor: 7.914
Authors: Willem E Hellings; Wouter Peeters; Frans L Moll; Sebastiaan R D Piers; Jessica van Setten; Peter J Van der Spek; Jean-Paul P M de Vries; Kees A Seldenrijk; Peter C De Bruin; Aryan Vink; Evelyn Velema; Dominique P V de Kleijn; Gerard Pasterkamp Journal: Circulation Date: 2010-04-19 Impact factor: 29.690
Authors: Hunter R Underhill; Chun Yuan; Vasily L Yarnykh; Baocheng Chu; Minako Oikawa; Nayak L Polissar; Stephen M Schwartz; Gail P Jarvik; Thomas S Hatsukami Journal: JACC Cardiovasc Imaging Date: 2009-12
Authors: George D Giannoglou; Konstantinos C Koskinas; Dimitrios N Tziakas; Antonios G Ziakas; Antonios P Antoniadis; Ioannis K Tentes; George E Parcharidis Journal: Angiology Date: 2009-06-17 Impact factor: 3.619
Authors: Erin M Kirkham; Thomas S Hatsukami; Susan R Heckbert; Jie Sun; Gador Canton; Chun Yuan; Edward M Weaver Journal: Otolaryngol Head Neck Surg Date: 2017-07-11 Impact factor: 3.497
Authors: Hongge Shu; Jie Sun; Thomas S Hatsukami; Niranjan Balu; Daniel S Hippe; Haining Liu; Ted R Kohler; Wenzhen Zhu; Chun Yuan Journal: J Magn Reson Imaging Date: 2017-02-06 Impact factor: 4.813
Authors: Xianling Wang; Jie Sun; Xihai Zhao; Daniel S Hippe; Thomas S Hatsukami; Jin Liu; Rui Li; Gador Canton; Yan Song; Chun Yuan Journal: Atherosclerosis Date: 2017-01-12 Impact factor: 5.162
Authors: Jin Liu; Jie Sun; Niranjan Balu; Marina S Ferguson; Jinnan Wang; William S Kerwin; Daniel S Hippe; Amy Wang; Thomas S Hatsukami; Chun Yuan Journal: J Magn Reson Imaging Date: 2019-03-12 Impact factor: 4.813
Authors: Mahmud Mossa-Basha; Hiroko Watase; Jie Sun; Dean K Shibata; Daniel S Hippe; Niranjan Balu; Thomas Hatsukami; Chun Yuan Journal: Br J Radiol Date: 2019-02-26 Impact factor: 3.039
Authors: Jin Liu; Niranjan Balu; Daniel S Hippe; Marina S Ferguson; Vanesa Martinez-Malo; J Kevin DeMarco; David C Zhu; Hideki Ota; Jie Sun; Dongxiang Xu; William S Kerwin; Thomas S Hatsukami; Chun Yuan Journal: J Cardiovasc Magn Reson Date: 2016-07-16 Impact factor: 5.364
Authors: Raf H M van Hoof; Evelien Hermeling; Judith C Sluimer; Julie Salzmann; Arnold P G Hoeks; Jérôme Roussel; Mat J A P Daemen; Harry Struijker-Boudier; Joachim E Wildberger; Sylvia Heeneman; M Eline Kooi Journal: PLoS One Date: 2017-06-22 Impact factor: 3.240
Authors: J Scott McNally; Seong-Eun Kim; Jason Mendes; J Rock Hadley; Akihiko Sakata; Adam H De Havenon; Gerald S Treiman; Dennis L Parker Journal: Magn Reson Insights Date: 2017-03-07